$0.576
+0.062 (+10.71%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
KTTA Prediction & Forecast by Similar Chart Analysis
Alphio's KTTA stock price prediction model matches the current Pasithea Therapeutics Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.57 (-1.04%). The 1-week path is $0.57 (-0.88%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Pasithea Therapeutics Corp Stock?
Pasithea Therapeutics Corp (KTTA) is a good buy right now due to its recent price increase of 55.51% over the last 5 days and the positive momentum indicated by an RSI of 81.843, suggesting strong buying pressure. The company has also received FDA clearance for its PAS-004 candidate, which could significantly enhance its market position in treating NF1-associated tumors. However, it is important to note that the company has a negative net income of -5,273,852 USD in Q2 2026, which poses a risk to its financial stability.
KTTA stock price ended at $0.58 on Friday, after rising +10.71%
Pasithea Therapeutics Corp (KTTA) last closed at $0.5757, gaining +10.71%. These facts feed the 1-day and 1-week KTTA price prediction above.
Forecast Drivers
Pasithea Therapeutics Corp (KTTA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches KTTA, ranked by similarity.
Seasonality analysis for KTTA
Historically the probability of a positive November return for KTTA is 0.00%. April offers the highest probability of a positive month at 7.81%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for KTTA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $0.61 | $0.74 | $0.75 | +28.48% |
| Dec 2026 | $0.78 | $0.83 | $0.95 | +43.76% |
In 2026, Pasithea Therapeutics Corp (KTTA) is projected to range from $0.61 to $0.95.
Pasithea Therapeutics Corp 2026 monthly forecast
In Nov 2026, Pasithea Therapeutics Corp is projected to average $0.74, with a low of $0.61 and high of $0.75.
In Dec 2026, Pasithea Therapeutics Corp is projected to average $0.83, with a low of $0.78 and high of $0.95.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.